Effect of age and of hypertrophy on cardiac Ca2+ antagonist binding sites.

We explored the effect of age and of hypertrophy on Ca2+ antagonist binding site density (Bmax), affinity (Kd), and selectivity in cardiac membranes harvested from the hearts of young adult (9-week-old) and older (25-week-old) Sprague Dawley (SD) rats, Wistar Kyoto rats (WKY), and spontaneously hypertensive rats (SHR). Radioligand binding studies with (+)[3H]PN200-110 failed to show a significant difference between the Bmax obtained for the cardiac membranes of 9-week-old SD, WKY, or SHR. Similarly, at 25 weeks, the Bmax values were the same for each group, but in each group the Bmax tended to increase with age. The Kd and selectivity were unchanged. For (-)[3H]D888 binding, the Kd values changed with age, but there was no hypertension or hypertrophy-linked increase in Bmax. In the SD and SHR series, but not in the WKY, there was a tendency for the Bmax to increase with age. We interpreted these results to mean that age may contribute to the different Kd and Bmax values described for cardiac membranes from 25-week-old WKY and SHR.
AuthorsJ S Dillon, X H Gu, W G Nayler
JournalJournal of cardiovascular pharmacology (J Cardiovasc Pharmacol) Vol. 14 Issue 2 Pg. 233-40 (Aug 1989) ISSN: 0160-2446 [Print] UNITED STATES
PMID2476596 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Calcium Channels
  • Dihydropyridines
  • Indicators and Reagents
  • Oxadiazoles
  • Receptors, Nicotinic
  • 4-desmethoxyverapamil
  • Verapamil
  • Isradipine
  • Aging (metabolism)
  • Animals
  • Blood Pressure (drug effects)
  • Body Weight (drug effects)
  • Calcium Channels
  • Cardiomegaly (metabolism)
  • Cell Membrane (metabolism)
  • Dihydropyridines (metabolism)
  • Indicators and Reagents
  • Isradipine
  • Male
  • Myocardium (metabolism)
  • Oxadiazoles (metabolism)
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred Strains
  • Rats, Inbred WKY
  • Receptors, Nicotinic (metabolism)
  • Time Factors
  • Verapamil (analogs & derivatives, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: